Joan E. M. van der Lubbe

Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe et al. · npj Vaccines · 2020 · 367 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +18

Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP

Laura Solforosi, Harmjan Kuipers, Mandy Jongeneelen et al. · The Journal of Experimental Medicine · 2021 · 69 citations · Full text

Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease

Joan E. M. van der Lubbe, Sietske K. Rosendahl Huber, Aneesh Vijayan et al. · npj Vaccines · 2021 · 47 citations · Full text

Ad26-vector based COVID-19 vaccine encoding a prefusion stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe et al. · 2020 · 45 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +18

Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice

Joan E. M. van der Lubbe, Johan Verspuij, Jeroen Huizingh et al. · Frontiers in Immunology · 2018 · 27 citations · Full text

Immunology, Immunodominance, Cd4 T Cell Responses +19